These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23811602)

  • 1. Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients.
    Savić V; Eržen B; Janić M; Lunder M; Boncelj M; Kanc K; Janež A; Šabović M
    Diab Vasc Dis Res; 2013 Sep; 10(5):420-5. PubMed ID: 23811602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial.
    Lunder M; Janić M; Jug B; Sabovič M
    Eur J Intern Med; 2012 Apr; 23(3):261-6. PubMed ID: 22385885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - The effect of a very low-dose combination of fluvastatin and valsartan.
    Boncelj Svetek M; Eržen B; Kanc K; Šabovič M
    J Diabetes Complications; 2017 Mar; 31(3):544-550. PubMed ID: 28012835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of age-associated arterial wall changes by low-dose valsartan.
    Lunder M; Janic M; Sabovic M
    Eur J Prev Cardiol; 2012 Dec; 19(6):1243-9. PubMed ID: 21933833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males.
    Janić M; Lunder M; Prezelj M; Šabovič M
    J Cardiopulm Rehabil Prev; 2014; 34(3):208-12. PubMed ID: 24263076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.
    Ruggenenti P; Perna A; Tonelli M; Loriga G; Motterlini N; Rubis N; Ledda F; Rota S; Satta A; Granata A; Battaglia G; Cambareri F; David S; Gaspari F; Stucchi N; Carminati S; Ene-Iordache B; Cravedi P; Remuzzi G;
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):1928-38. PubMed ID: 20671225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of valsartan, fluvastatin extended release and their combination on arterial pressure, parameters of lipid metabolism, and endothelial function in patients with hypertensive disease].
    Soboleva GN; Pogorelova OA; Kuznetsova TV; Masenko VP; Fomicheva OA; Chernova NA; Rogoza AN; Balakhonova TV; Karpov IuA
    Kardiologiia; 2007; 47(11):9-13. PubMed ID: 18260957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus.
    Lunder M; Janić M; Savić V; Janež A; Kanc K; Šabovič M
    Diabetes Res Clin Pract; 2017 May; 127():181-186. PubMed ID: 28384560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males--a pilot study.
    Lunder M; Janić M; Habjan S; Sabovič M
    Atherosclerosis; 2011 Apr; 215(2):446-51. PubMed ID: 21300350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of arterial wall phenotype in subjects at moderate cardiovascular risk induced by very low-dose fluvastatin/valsartan combination: a pilot study.
    Turk Veselič M; Žorž N; Eržen B; Škerl P; Novaković S; Janić M; Šabovič M
    Int Angiol; 2018 Oct; 37(5):356-364. PubMed ID: 29952159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic.
    Takami T
    Hypertens Res; 2009 Dec; 32(12):1086-90. PubMed ID: 19779491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.
    Munakata M; Nagasaki A; Nunokawa T; Sakuma T; Kato H; Yoshinaga K; Toyota T
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1050-5. PubMed ID: 15533733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term improvement of arterial wall characteristics in patients with diabetes mellitus type 1 using cyclic, intermittent treatment with a low-dose fluvastatin and valsartan combination.
    Savić V; Janić M; Lunder M; Kanc K; Janež A; Eržen B; Šabovič M
    Exp Ther Med; 2015 Sep; 10(3):1207-1211. PubMed ID: 26622466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation.
    Horiuchi M; Cui TX; Li Z; Li JM; Nakagami H; Iwai M
    Circulation; 2003 Jan; 107(1):106-12. PubMed ID: 12515751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Dose Fluvastatin and Valsartan Rejuvenate the Arterial Wall Through Telomerase Activity Increase in Middle-Aged Men.
    Janić M; Lunder M; Cerkovnik P; Prosenc Zmrzljak U; Novaković S; Šabovič M
    Rejuvenation Res; 2016 Apr; 19(2):115-9. PubMed ID: 26214555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A; Rahman AR; Rasool AH
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valsartan therapy has additive anti-oxidative effect to that of fluvastatin therapy against low-density lipoprotein oxidation: studies in hypercholesterolemic and hypertensive patients.
    Hussein O; Shneider J; Rosenblat M; Aviram M
    J Cardiovasc Pharmacol; 2002 Jul; 40(1):28-34. PubMed ID: 12072574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
    Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.